ATE386528T1 - Kombination von glivec (sti571) mit einem cyclinabhängigen kinaseinhibitoren, ins besonders flavopiridol, zur behandlung von krebs - Google Patents

Kombination von glivec (sti571) mit einem cyclinabhängigen kinaseinhibitoren, ins besonders flavopiridol, zur behandlung von krebs

Info

Publication number
ATE386528T1
ATE386528T1 AT03712531T AT03712531T ATE386528T1 AT E386528 T1 ATE386528 T1 AT E386528T1 AT 03712531 T AT03712531 T AT 03712531T AT 03712531 T AT03712531 T AT 03712531T AT E386528 T1 ATE386528 T1 AT E386528T1
Authority
AT
Austria
Prior art keywords
cyclin
cancer
treatment
combination
kinase inhibitor
Prior art date
Application number
AT03712531T
Other languages
English (en)
Inventor
Paul Dent
Steven Grant
Geoffrey Krystal
Chunrong Yu
Original Assignee
Univ Virginia Commonwealth
Us Gov Veterans Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Virginia Commonwealth, Us Gov Veterans Affairs filed Critical Univ Virginia Commonwealth
Application granted granted Critical
Publication of ATE386528T1 publication Critical patent/ATE386528T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
AT03712531T 2002-04-10 2003-04-04 Kombination von glivec (sti571) mit einem cyclinabhängigen kinaseinhibitoren, ins besonders flavopiridol, zur behandlung von krebs ATE386528T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37133002P 2002-04-10 2002-04-10

Publications (1)

Publication Number Publication Date
ATE386528T1 true ATE386528T1 (de) 2008-03-15

Family

ID=28792053

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03712531T ATE386528T1 (de) 2002-04-10 2003-04-04 Kombination von glivec (sti571) mit einem cyclinabhängigen kinaseinhibitoren, ins besonders flavopiridol, zur behandlung von krebs

Country Status (8)

Country Link
US (1) US7888341B2 (de)
EP (1) EP1496908B1 (de)
JP (1) JP4429732B2 (de)
AT (1) ATE386528T1 (de)
AU (1) AU2003216621A1 (de)
DE (1) DE60319211T2 (de)
ES (1) ES2303585T3 (de)
WO (1) WO2003084543A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) * 2002-04-23 2002-06-05 Novartis Ag Organic compounds
CN100467064C (zh) * 2003-09-19 2009-03-11 诺瓦提斯公司 伊马替尼和米哚妥林在制备治疗胃肠道基质肿瘤药物中的应用
JP5033624B2 (ja) * 2004-07-09 2012-09-26 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ ＧＳＫ−３βの変更および増殖性疾患の治療方法
JP5084736B2 (ja) * 2005-11-10 2012-11-28 バイエル・ファルマ・アクチェンゲゼルシャフト 肺高血圧を処置するためのジアリールウレア
US8563595B2 (en) * 2008-11-14 2013-10-22 Board Of Regents, The University Of Texas System Treatment of cancer with complex organic-inorganic pigment compositions
WO2022217068A1 (en) * 2021-04-09 2022-10-13 Dna-Seq, Inc. Methods of treatment for leukemia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003511396A (ja) 1999-10-08 2003-03-25 オントジエン・コーポレイシヨン 化学療法を増強する方法
US20020147197A1 (en) 1999-10-08 2002-10-10 Newman Michael J. Methods and compositions for enhancing pharmaceutical treatments

Also Published As

Publication number Publication date
ES2303585T3 (es) 2008-08-16
DE60319211T2 (de) 2009-02-12
EP1496908B1 (de) 2008-02-20
DE60319211D1 (de) 2008-04-03
EP1496908A1 (de) 2005-01-19
AU2003216621A8 (en) 2003-10-20
WO2003084543A1 (en) 2003-10-16
US7888341B2 (en) 2011-02-15
AU2003216621A1 (en) 2003-10-20
US20050176725A1 (en) 2005-08-11
JP4429732B2 (ja) 2010-03-10
JP2005526821A (ja) 2005-09-08

Similar Documents

Publication Publication Date Title
DK1332137T3 (da) Behandling af gastrointestinale stromale tumorer
TWI347186B (en) Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide
PL338129A1 (en) Crystalline form of a derivative of n-phenyl-2-dipyrimidin amine, methods of obtaining same and apllication thereof
ATE400567T1 (de) Kinaseinhibitoren
ATE360627T1 (de) Pyrrolidindion-substituierte piperidin- phthalazone als pde4-inhibitoren
EA200500862A1 (ru) Синоменин и соединения синоменина, синтез и применение
ATE469896T1 (de) Aminosäuresalze von rosiglitazon
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
ATE521354T1 (de) Kombination aus imatinib und einem histondeacetylase-hemmer zur behandlung von leukämie
SE0103710D0 (sv) Compounds
ATE386528T1 (de) Kombination von glivec (sti571) mit einem cyclinabhängigen kinaseinhibitoren, ins besonders flavopiridol, zur behandlung von krebs
ATE287403T1 (de) 6-phenylbenzonaphthyidine
BR0316126A (pt) Combinação de compostos para o tratamento de leucemia linfocìtica crÈnica
DK1471916T3 (da) Behandling af rheumatoid arthritis under anvendelse af imatinib
DE602004022540D1 (de) Verwendung von tyrosin-kinase-hemmern zur behandlung von diabetes
TH117316B (th) มอนอไซคลิค เฮเทอโรไซเคิลในฐานะเป็นตัวยับยั้งไคเนส
DE60305460D1 (de) Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties